IG
Ivan Gergel
Managing Partner at New Rhein Healthcare Investors
Philadelphia, Pennsylvania
Overview
Ivan Gergel is the Managing Partner and Chief Medical Officer at New Rhein Healthcare Investors LLC in Philadelphia, Pennsylvania. With a background in clinical development and drug discovery, he has served as the Head of Development & Chief Medical Officer at Nektar Therapeutics and has invested in companies like Corsair Pharma at Series B stage.
Gergel's career highlights include his role as Chairman of the Board of Directors at Corsair Pharma and his current position at New Rhein Healthcare Investors, where he leads cross-functional teams in the pharmaceutical industry focusing on clinical trials and commercialization.
Work Experience
Chairman of the Board of Directors
2023 - Current
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.
Raised $23,000,000.00 from Primavera Capital Group, Junson Capital, New Rhein, Midas Capital and Plaisance Capital Management.
Director Board of Directors
2022
Director Board of Directors
2020
Managing Partner and Chief Medical Officer
2018
Director Board of Directors
2018
Director Board of Directors
2021 - 2022
Director Board of Directors
2018 - 2020
Director Board of Directors
2016 - 2019
Director Board of Directors
2014 - 2018
Head of Development & Chief Medical Officer
2014 - 2017
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Raised $1,199,999,960.00 from SFJ Pharmaceuticals, AstraZeneca and New Enterprise Associates.